Neurocrine Biosciences Inc NBIX

Pfizer Rejects Indiplon

[scissors14]

U.S. Equity News: AstraZeneca Cholesterol Drug Effective and Abbott Phase III Data Jun 26, 2006 (M2 PRESSWIRE via COMTEX News Network) -- City of Industry, CA - June 26, 2006 - Pharmaceuticals Instruments industry alert provided by U.S. Equity News. British drug maker AstraZeneca PLC (NYSE:AZN) said Thursday that results from three clinical trials showed its Crestor medication lowered LDL-C, or "bad cholesterol," levels in Americans of certain ethnic populations. The company said it conducted separate six-week clinical trials with African-American, Hispanic and South Asian patients with high cholesterol, comparing Crestor with atorvastatin, the generic version of Pfizer Inc.'s cholesterol-reducing drug, Lipitor. Pfizer Inc (NYSE:PFE) said recently it is returning to Neurocrine Biosciences, Inc. the development and marketing rights for Indiplon, a medicine in development to treat insomnia. This includes both the collaboration to develop and co-market Indiplon in the U.S. as well as Pfizer's exclusive license to develop and market Indiplon outside of the U.S. Abbott Laboratories (NYSE:ABT) said two analyses of a Phase III study of Humira to treat ankylosing spondylitis demonstrates that it's able to reduce the signs and symptoms in patients from 12 weeks to 52 weeks and that it rapidly and significantly reduces pain and fatigue. Abbott's application for Humira for AS in the United States is currently under review. CytoDyn, Inc. (OTCBB:CYDY) was advised recently that Team Hope, the charity bicycle riders sponsored by the Company, earned $10,910 for the Emory Vaccine Center during this year's Action Cycling 200, a challenging two-day, 200-mile bicycle ride that took place the weekend of May 20-21, 2006 in Georgia. This is as compared to $6,545 contributed by the next highest earning team. A total of $55,463 was raised for the Vaccine Center at Emory University. About U.S. Equity News U.S. Equity News provides information, resources and news services for investors of small-cap, micro-cap and emerging companies. U.S. Equity News distributes RSS news feeds and a free subscription-based newsletter available through its website at www.usequitynews.com. U.S. Equity News is a financial news distribution service by Equity Solutions, Inc. (www.equityirsolutions.com) that provides a platform for public companies to disseminate important news to key Wall Street interest such as shareholders and new investors. Equity Solutions, Inc. can assist by providing an effective increase in the awareness of a public company's news, development and corporate story through its proprietary network and its financial portal. CONTACT: U.S. Equity News Tel: [phone] E-mail: [e-mail] Eddie Cruz, President, Equity Solutions, Inc. Tel: [phone] Tel: [phone] Tel: [phone] WWW: https://www.equityirsolutions.com WWW: https://www.USEquityNews.com M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at https://www.presswire.net on the world wide web. Inquiries to [e-mail]. (C)1994-2006 M2 COMMUNICATIONS LTD